Many research projects that involve BSL3 agents greatly improve their likelihood for funding by including critical proof-of-concept data. However, acquiring such data requires established facilities and personnel versed in technical aspects to conduct biosafe experiments to the investigators expectations. To assist in deriving critical proof-of-concept data, we have instituted a Fee for Service mechanism for BSL3 and ABSL3 experiments that leverage approved procedures, pathogens and personnel to rapidly and accurately complete desired experiments. Areas of BSL3/ABSL3 expertise include conducting the following types of experiments with emerging and zoonotic pathogens:
- Modeling In vitro and In vivo pathogenesis
- DNA/RNA/Protein isolation
- Antimicrobial/Antiviral testing
- Pathogen challenge studies for vaccine and therapeutic development and testing
- In vitro imaging of tissue culture infection model
- High throughput screening
Available to ISU, Ames Research Park and both U.S. and International Biotechnology entities.
Contact Dr. Bryan Bellaire, bbella@iastate.edu for further information.